GenesisCare conducts internationally recognised, high-quality clinical trials. Our doctors and research staff have a wealth of knowledge and expertise that’s helping to improve healthcare in the UK and around the world. 

Our clinicians believe that new treatments should only be adopted once adequate assessment has taken place to confirm their effectiveness and safety. The research of today gives us new treatments for tomorrow.

A clinical trial is a medical study involving volunteers to develop new treatments, interventions, or tests to detect, treat or manage various diseases and medical conditions.

Some trials examine how people respond to a new treatment and identify possible side effects. This helps us determine how a new treatment works, whether it’s safe, and if it’s better than other treatments that are already available.

Clinical trials might also compare existing treatments, test new ways to use or combine existing treatments, or observe how people respond to other factors that might affect their health, such as dietary changes.

Other trials look at ways to diagnose diseases earlier or how to prevent particular diseases and medical conditions.

Scientists and healthcare professionals rely on the results from clinical trials to make new and better treatments available to those that need them. This is only possible with the help of the people who volunteer to take part in clinical trials. The more people in our clinical trials, the faster new treatments can become available to the community.

We believe every patient with cancer deserves the option of a clinical trial with access to novel, innovative, cutting-edge treatments offered by leading clinical experts.

Clinical trials for new treatments start out by testing the treatment in a small number of people to assess safety and effectiveness. 

If the results are promising, the treatment moves to later stages of testing where we collect more information on effectiveness and possible side effects by increasing the number of people in the clinical trial. The new treatment is usually compared to another treatment already in use, or a placebo, depending on what the standard of care is for that particular need. 

If the treatment passes these stages, it becomes licensed for use in regular practice for those who need it. Most treatments will continue to be studied in practice to collect data that helps optimise the treatment further and monitor long-term outcomes and side effects.

All research conducted by GenesisCare conforms to the World Medical Association Declaration of Helsinki (ethical principles for medical research involving human subjects) and to international Good Clinical Practice guidelines. Before research can go ahead in the UK, it’s approved by an independent ethics committee that operates according to the guidelines issued by the Medicines and Healthcare products Regulatory Agency (MHRA). 

Our clinical research in the UK currently takes place at our Windsor, Cambridge and Oxford sites. We also have a research partnership with the University of Oxford where the The Oxford Institute for Radiation Oncology is one of the world’s leading centres for radiotherapy-related research.

Every patient gets the standard of care treatment – either alone or combined with a new treatment. Our job is to work with you to make sure that new treatments live up to their claims. 

It’s important you know that you’re not obliged in any way to take part in a clinical trial. If you do take part, you can withdraw at any time without it affecting your ongoing medical care.